Pub. Date : 2021 Jul
PMID : 33970400
3 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | The Role of p53 Expression in Patients with RAS/BRAF Wild-Type Metastatic Colorectal Cancer Receiving Irinotecan and Cetuximab as Later Line Treatment. | Irinotecan | tumor protein p53 | Homo sapiens |
2 | OBJECTIVE: In our study, we evaluated the role of p53 expression in patients with RAS/BRAF wild-type metastatic colorectal cancer (mCRC) receiving irinotecan/cetuximab in an exploratory and a validation cohort. | Irinotecan | tumor protein p53 | Homo sapiens |
3 | PATIENTS AND METHODS: p53 expression was analysed in patients with RAS/BRAF wild-type mCRC receiving second-line or third-line irinotecan/cetuximab. | Irinotecan | tumor protein p53 | Homo sapiens |